Education ▼

SPECIALTY TOPICS

CURRENTLY VIEWING
Colorectal Cancer

Breast Cancer

Gastrointestinal Cancer

Colorectal Cancer

Neoadjuvant, Nonoperative Regimens Being Investigated in Rectal Cancer

Katherine Van Loon, MD, MPH, discusses the emerging use of neoadjuvant therapy and nonoperative approaches for patients with locally advanced rectal cancer.
Read More >>

Precision Medicine Impact Grows in GI Cancer Paradigm

Expert Sheds Light on Recent Advances in mCRC

FDA Grants Nivolumab/Ipilimumab Priority Review for MSI-H/dMMR Colorectal Cancer

Immunotherapy, Sidedness Strategies Enhancing mCRC Treatment

Atezolizumab, Cobimetinib Combo Active in mCRC

View More Stories >>

View Conference Coverage

2018 AACR Annual Meeting

2018 European Lung Cancer Congress

2018 SGO Annual Meeting

2018 State of the Science Summit on Gastrointestinal Malignancies

2018 State of the Science Summit on Prostate Cancer

Dr. Kopetz Discusses the Treatment of BRAF-Mutant CRC

Dr. Bhoola on Enhanced Recovery After Surgery in Gynecologic Cancer

Dr. Van Loon Discusses the Management of Rectal Cancer

Dr. Bekaii-Saab Discusses the Next Steps With Regorafenib in CRC

Dr. O'Neil Discusses the Current Treatment of Patients With CRC

Dr. Pant on the Future of mCRC Treatment

OncLive houses thousands of videos that provide updates and information.
See more Videos

$Immunotherapy Options in Refractory CRC$

Immunotherapy Options in Refractory CRC

Supportive Care in Metastatic CRC

Maintenance and Second-Line Decisions in CRC

Frontline Antibody Selection in Metastatic CRC

Role of Molecular Testing in CRC Management

OncLive houses thousands of videos that provide updates and information.
See more Videos

Biomarkers and Novel Approaches in CRC

Reverce Study: Outcomes and Impact

$Sequencing of Therapy in Refractory mCRC$

Sequencing of Therapy in Refractory mCRC

Proactive Side Effect Management With Regorafenib

Clinical Implications of the ReDOS Findings

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured Programs

Treatment Goals in Refractory mCRC

$Treatment Goals in Refractory mCRC$
Tanios Bekaii-Saab, MD, FACP, Andrea Cercek, MD, and Zev A. Wainberg, MD, provide insight to the treatment goals for patients with refractory metastatic colorectal cancer.

View Now

Therapeutic Strategies in Metastatic Colorectal Cancer

Recent advances in the treatment of metastatic colorectal cancer (mCRC) have improved survival. However, many questions remain. Led by John L. Marshall, MD, panelists Tanios Bekaii-Saab, MD; Johanna Bendell, MD; Richard Kim, MD; and Charles S. Fuchs, MD, MPH, discuss strategies and approaches to managing mCRC, including the latest research and how it may influence clinical practice.

View Now

Featured Video

Immunotherapy in the Treatment of Follicular Lymphoma

Ian W. Flinn, MD, PhD; Grzegorz S. Nowakowski, MD; Loretta J. Nastoupil, MD; and Anas Younes, MD, reflect on the value of immunotherapy, immunotherapy combination strategies, and understanding the tumor microenvironment in treating follicular lymphoma.View now

FDA Approvals in RCC and Chronic ITP, 2018 ELCC Highlights, and More